Impact of Sleep Disorder as a Risk Factor for Dementia in Men and Women |
Jee, Hye Jin
(College of Pharmacy, Ajou University)
Shin, Wonseok (College of Pharmacy, Ajou University) Jung, Ho Joong (College of Pharmacy, Ajou University) Kim, Baekgyu (Graduate School of Global Pharmaceutical Industry and Clinical Pharmacy, Ajou University) Lee, Bo Kyung (College of Pharmacy, Ajou University) Jung, Yi-Sook (College of Pharmacy, Ajou University) |
1 | Fatani, A., Al-Rouqi, K., Al Towairky, J., Ahmed, A. E., Al-Jahdali, S., Ali, Y., Al-Shimemeri, A., Al-Harbi, A., Baharoon, S., Khan, M. and Al-Jahdali, H. (2015) Effect of age and gender in the prevalence of excessive daytime sleepiness among a sample of the Saudi population. J. Epidemiol. Glob. Health 5, S59-S66. DOI |
2 | Fleetham, J. A. and Fleming, J. A. (2014) Parasomnias. CMAJ 186, E273-E280. DOI |
3 | Foley, D., Monjan, A., Masaki, K., Ross, W., Havlik, R., White, L. and Launer, L. (2001) Daytime sleepiness is associated with 3-year incident dementia and cognitive decline in older Japanese-American men. J. Am. Geriatr. Soc. 49, 1628-1632. DOI |
4 | Foley, D. J., Monjan, A. A., Brown, S. L., Simonsick, E. M., Wallace, R. B. and Blazer, D. G. (1995) Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 18, 425-432. DOI |
5 | Gabbay, F. H. (2003) Variations in affect following amphetamine and placebo: markers of stimulant drug preference. Exp. Clin. Psychopharmacol. 11, 91-101. DOI |
6 | Gehrman, P., Marler, M., Martin, J. L., Shochat, T., Corey-Bloom, J. and Ancoli-Israel, S. (2004) The timing of activity rhythms in patients with dementia is related to survival. J. Gerontol. A Biol. Sci. Med. Sci. 59, 1050-1055. DOI |
7 | George, A. J. (2000) Central nervous system stimulants. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 14, 79-88. DOI |
8 | Gjerstad, M. D., Alves, G., Wentzel-Larsen, T., Aarsland, D. and Larsen, J. P. (2006) Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 67, 853-858. DOI |
9 | Golden, L. C. and Voskuhl, R. (2017) The importance of studying sex differences in disease: the example of multiple sclerosis. J. Neurosci. Res. 95, 633-643. DOI |
10 | Green, R. C., Cupples, L. A., Kurz, A., Auerbach, S., Go, R., Sadovnick, D., Duara, R., Kukull, W. A., Chui, H., Edeki, T., Griffith, P. A., Friedland, R. P., Bachman, D. and Farrer, L. (2003) Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch. Neurol. 60, 753-759. DOI |
11 | Greenblatt, D. J., Harmatz, J. S. and Karim, A. (2007) Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2. J. Clin. Pharmacol. 47, 485-496. DOI |
12 | Greenblatt, D. J., Harmatz, J. S., von Moltke, L. L., Wright, C. E. and Shader, R. I. (2004) Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate. Clin. Pharmacol. Ther. 76, 467-479. DOI |
13 | Gu, D., Sautter, J., Pipkin, R. and Zeng, Y. (2010) Sociodemographic and health correlates of sleep quality and duration among very old Chinese. Sleep 33, 601-610. |
14 | Hara, C., Lopes Rocha, F. and Lima-Costa, M. F. (2004) Prevalence of excessive daytime sleepiness and associated factors in a Brazilian community: the Bambui study. Sleep Med. 5, 31-36. DOI |
15 | Guarnieri, B. (2019) Sleep disorders and cognitive alterations in women. Maturitas 126, 25-27. DOI |
16 | Guo, T., Mao, G., Zhao, L., Xia, D. and Yang, L. (2014) Comparative pharmacokinetics of zolpidem tartrate in five ethnic populations of China. Acta Pharm. Sin. B 4, 146-150. DOI |
17 | Guo, T., Zhao, L. S. and Xia, D. Y. (2010) Pharmacokinetic study of modafinil in relation to gender and ethnicity in healthy young Chinese volunteers. J. Pharm. Pharm. Sci. 13, 443-449. DOI |
18 | Hayley, A. C., Williams, L. J., Kennedy, G. A., Berk, M., Brennan, S. L. and Pasco, J. A. (2014) Prevalence of excessive daytime sleepiness in a sample of the Australian adult population. Sleep Med. 15, 348-354. DOI |
19 | Heaney, R. P. (2001) Factors influencing the measurement of bioavailability, taking calcium as a model. J. Nutr. 131, 1344S-1348S. DOI |
20 | Herring, W. J., Connor, K. M., Snyder, E., Snavely, D. B., Zhang, Y., Hutzelmann, J., Matzura-Wolfe, D., Benca, R. M., Krystal, A. D., Walsh, J. K., Lines, C., Roth, T. and Michelson, D. (2017) Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data. Psychopharmacology (Berl.) 234, 1703-1711. DOI |
21 | Hobson, D. E., Lang, A. E., Martin, W. R., Razmy, A., Rivest, J. and Fleming, J. (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 287, 455-463. DOI |
22 | Hutchinson, M. A., Smith, P. F. and Darlington, C. L. (1996) The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs. Prog. Neurobiol. 49, 73-97. DOI |
23 | Hofman, M. A. and Swaab, D. F. (2006) Living by the clock: the circadian pacemaker in older people. Ageing Res. Rev. 5, 33-51. DOI |
24 | Howell, M. J. (2012) Parasomnias: an updated review. Neurotherapeutics 9, 753-775. DOI |
25 | Hung, C. M., Li, Y. C., Chen, H. J., Lu, K., Liang, C. L., Liliang, P. C., Tsai, Y. D. and Wang, K. W. (2018) Risk of dementia in patients with primary insomnia: a nationwide population-based case-control study. BMC Psychiatry 18, 38. DOI |
26 | Ihara, M., Tomimoto, H., Ishizu, K., Mukai, T., Yoshida, H., Sawamoto, N., Inoue, M., Doi, T., Hashikawa, K., Konishi, J., Shibasaki, H. and Fukuyama, H. (2004) Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: a positron emission tomography study. Stroke 35, 942-947. DOI |
27 | Innes, K. E., Flack, K. L., Selfe, T. K., Kandati, S. and Agarwal, P. (2013) Restless legs syndrome in an appalachian primary care population: prevalence, demographic and lifestyle correlates, and burden. J. Clin. Sleep Med. 9, 1065-1075. DOI |
28 | Ip, M. S., Lam, B., Ng, M. M., Lam, W. K., Tsang, K. W. and Lam, K. S. (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am. J. Respir. Crit. Care Med. 165, 670-676. DOI |
29 | Iranzo, A., Santamaria, J. and Tolosa, E. (2016) Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol. 15, 405-419. DOI |
30 | Kazaglis, L. and Bornemann, M. A. C. (2016) Classification of parasomnias. Curr. Sleep Medicine Rep. 2, 45-52. DOI |
31 | Keitt, S. K., Fagan, T. F. and Marts, S. A. (2004) Understanding sex differences in environmental health: a thought leaders' roundtable. Environ. Health Perspect. 112, 604-609. DOI |
32 | Khan, Z. and Trotti, L. M. (2015) Central disorders of hypersomnolence: focus on the narcolepsies and idiopathic hypersomnia. Chest 148, 262-273. DOI |
33 | Kiley, J. P., Twery, M. J. and Gibbons, G. H. (2019) The National Center on Sleep Disorders Research-progress and promise. Sleep 42, zsz105. DOI |
34 | Kim, H. I., Lim, H. and Moon, A. (2018) Sex differences in cancer: epidemiology, genetics and therapy. Biomol. Ther. (Seoul) 26, 335-342. DOI |
35 | Kim, H. M., Gerlach, L. B., Van, T., Yosef, M., Conroy, D. A. and Zivin, K. (2019) Predictors of long-term and high-dose use of zolpidem in Veterans. J. Clin. Psychiatry 80, 18m12149. |
36 | Kim, J. M., Stewart, R., Kim, S. W., Yang, S. J., Shin, I. S. and Yoon, J. S. (2009) Insomnia, depression, and physical disorders in late life: a 2-year longitudinal community study in Koreans. Sleep 32, 1221-1228. DOI |
37 | Allen, R. P. and Earley, C. J. (1996) Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19, 205-213. DOI |
38 | Anderson, K. N. and Shneerson, J. M. (2009) Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J. Clin. Sleep Med. 5, 235-239. DOI |
39 | Arnulf, I., Neutel, D., Herlin, B., Golmard, J. L., Leu-Semenescu, S., Cochen de Cock, V. and Vidailhet, M. (2015) Sleepiness in idiopathic REM sleep behavior disorder and parkinson disease. Sleep 38, 1529-1535. DOI |
40 | Islam, M. M., Iqbal, U., Walther, B., Atique, S., Dubey, N. K., Nguyen, P. A., Poly, T. N., Masud, J. H., Li, Y. J. and Shabbir, S. A. (2016) Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology 47, 181-191. DOI |
41 | Jacobs, M. L., Dauvilliers, Y., St Louis, E. K., McCarter, S. J., Romenets, S. R., Pelletier, A., Cherif, M., Gagnon, J. F. and Postuma, R. B. (2016) Risk factor profile in Parkinson's disease subtype with REM sleep behavior disorder. J. Parkinsons Dis. 6, 231-237. DOI |
42 | Jaussent, I., Bouyer, J., Ancelin, M. L., Berr, C., Foubert-Samier, A., Ritchie, K., Ohayon, M. M., Besset, A. and Dauvilliers, Y. (2012) Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep 35, 1201-1207. DOI |
43 | Joo, S., Baik, I., Yi, H., Jung, K., Kim, J. and Shin, C. (2009) Prevalence of excessive daytime sleepiness and associated factors in the adult population of Korea. Sleep Med. 10, 182-188. DOI |
44 | Joo, S., Shin, C., Kim, J., Yi, H., Ahn, Y., Park, M., Kim, J. and Lee, S. (2005) Prevalence and correlates of excessive daytime sleepiness in high school students in Korea. Psychiatry Clin. Neurosci. 59, 433-440. DOI |
45 | Jordan, A. S., McSharry, D. G. and Malhotra, A. (2014) Adult obstructive sleep apnoea. Lancet 383, 736-747. DOI |
46 | Ju, Y. E., Larson-Prior, L. and Duntley, S. (2011) Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. Sleep Med. 12, 278-283. DOI |
47 | Kang, J. E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., Fujiki, N., Nishino, S. and Holtzman, D. M. (2009) Amyloidbeta dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005-1007. DOI |
48 | Aurora, R. N., Zak, R. S., Maganti, R. K., Auerbach, S. H., Casey, K. R., Chowdhuri, S., Karippot, A., Ramar, K., Kristo, D. A., Morgenthaler, T. I.; Standards of Practice Committee; American Academy of Sleep Medicine (2010) Best practice guide for the treatment of REM sleep behavior disorder (RBD). J. Clin. Sleep Med. 6, 85-95. DOI |
49 | Aston-Jones, G. and Cohen, J. D. (2005) An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 28, 403-450. DOI |
50 | Aurora, R. N., Kristo, D. A., Bista, S. R., Rowley, J. A., Zak, R. S., Casey, K. R., Lamm, C. I., Tracy, S. L., Rosenberg, R. S.; American Academy of Sleep Medicine (2012) The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 35, 1039-1062. |
51 | Becker, J. B., Arnold, A. P., Berkley, K. J., Blaustein, J. D., Eckel, L. A., Hampson, E., Herman, J. P., Marts, S., Sadee, W., Steiner, M., Taylor, J. and Young, E. (2005) Strategies and methods for research on sex differences in brain and behavior. Endocrinology 146, 1650-1673. DOI |
52 | Benbir, G. and Guilleminault, C. (2006) Pramipexole: new use for an old drug-the potential use of pramipexole in the treatment of restless legs syndrome. Neuropsychiatr. Dis. Treat. 2, 393-405. DOI |
53 | Benedict, C., Byberg, L., Cedernaes, J., Hogenkamp, P. S., Giedratis, V., Kilander, L., Lind, L., Lannfelt, L. and Schioth, H. B. (2015) Selfreported sleep disturbance is associated with Alzheimer's disease risk in men. Alzheimers Dement. 11, 1090-1097. DOI |
54 | Bennett, T., Bray, D. and Neville, M. W. (2014) Suvorexant, a dual orexin receptor antagonist for the management of insomnia. P T 39, 264-266. |
55 | Buysse, D. J. (2013) Insomnia. JAMA 309, 706-716. DOI |
56 | Borgen, L. A., Okerholm, R., Morrison, D. and Lai, A. (2003) The influence of gender and food on the pharmacokinetics of sodium oxybate oral solution in healthy subjects. J. Clin. Pharmacol. 43, 59-65. DOI |
57 | Boutrel, B. and Koob, G. F. (2004) What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 27, 1181-1194. DOI |
58 | Breslau, N., Roth, T., Rosenthal, L. and Andreski, P. (1996) Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol. Psychiatry 39, 411-418. DOI |
59 | Chait, L. D. (1993) Factors influencing the reinforcing and subjective effects of d-amphetamine in humans. Behav. Pharmacol. 4, 191-199. DOI |
60 | Chait, L. D. (1994) Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology (Berl.) 113, 381-387. DOI |
61 | Chang, W. P., Liu, M. E., Chang, W. C., Yang, A. C., Ku, Y. C., Pai, J. T., Huang, H. L. and Tsai, S. J. (2013) Sleep apnea and the risk of dementia: a population-based 5-year follow-up study in Taiwan. PLoS ONE 8, e78655. DOI |
62 | Chaudhury, D., Wang, L. M. and Colwell, C. S. (2005) Circadian regulation of hippocampal long-term potentiation. J. Biol. Rhythms 20, 225-236. DOI |
63 | Chen, L., Bell, J. S., Visvanathan, R., Hilmer, S. N., Emery, T., Robson, L., Hughes, J. M. and Tan, E. C. (2016) The association between benzodiazepine use and sleep quality in residential aged care facilities: a cross-sectional study. BMC Geriatr. 16, 196. DOI |
64 | Bjurstrom, M. F. and Irwin, M. R. (2019) Perioperative pharmacological sleep-promotion and pain control: a systematic review. Pain Pract. 19, 552-569. DOI |
65 | Berdyyeva, T., Otte, S., Aluisio, L., Ziv, Y., Burns, L. D., Dugovic, C., Yun, S., Ghosh, K. K., Schnitzer, M. J., Lovenberg, T. and Bonaventure, P. (2014) Zolpidem reduces hippocampal neuronal activity in freely behaving mice: a large scale calcium imaging study with miniaturized fluorescence microscope. PLoS ONE 9, e112068. DOI |
66 | Bixler, E. O., Vgontzas, A. N., Lin, H. M., Ten Have, T., Rein, J., Vela-Bueno, A. and Kales, A. (2001) Prevalence of sleep-disordered breathing in women: effects of gender. Am. J. Respir. Crit. Care Med. 163, 608-613. DOI |
67 | Bixler, E. O., Vgontzas, A. N., Lin, H. M., Vela-Bueno, A. and Kales, A. (2002) Insomnia in central Pennsylvania. J. Psychosom. Res. 53, 589-592. DOI |
68 | Bliwise, D. L. (1993) Sleep in normal aging and dementia. Sleep 16, 40-81. DOI |
69 | Boeuf-Cazou, O., Bongue, B., Ansiau, D., Marquie, J. C. and Lapeyre-Mestre, M. (2011) Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort. Eur. J. Clin. Pharmacol. 67, 1045-1052. DOI |
70 | Bokenberger, K., Strom, P., Dahl Aslan, A. K., Johansson, A. L., Gatz, M., Pedersen, N. L. and Akerstedt, T. (2017) Association between sleep characteristics and incident dementia accounting for baseline cognitive status: a prospective population-based study. J. Gerontol. A Biol. Sci. Med. Sci. 72, 134-139. DOI |
71 | Bonakis, A., Howard, R. S., Ebrahim, I. O., Merritt, S. and Williams, A. (2009) REM sleep behaviour disorder (RBD) and its associations in young patients. Sleep Med. 10, 641-645. DOI |
72 | Cricco, M., Simonsick, E. M. and Foley, D. J. (2001) The impact of insomnia on cognitive functioning in older adults. J. Am. Geriatr. Soc. 49, 1185-1189. DOI |
73 | Chen, P. L., Lee, W. J., Sun, W. Z., Oyang, Y. J. and Fuh, J. L. (2012) Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study. PLoS ONE 7, e49113. DOI |
74 | Cheng, H. T., Lin, F. J., Erickson, S. R., Hong, J. L. and Wu, C. H. (2017) The association between the use of zolpidem and the risk of Alzheimer's disease among older people. J. Am. Geriatr. Soc. 65, 2488-2495. DOI |
75 | Cordovilla-Guardia, S., Lardelli-Claret, P., Vilar-Lopez, R., Lopez-Espuela, F., Guerrero-Lopez, F. and Fernandez-Mondejar, E. (2019) The effect of central nervous system depressant, stimulant and hallucinogenic drugs on injury severity in patients admitted for trauma. Gac. Sanit. 33, 4-9. DOI |
76 | Crowley, K. (2011) Sleep and sleep disorders in older adults. Neuropsychol. Rev. 21, 41-53. DOI |
77 | Culebras, A. and Anwar, S. (2018) Sleep apnea is a risk factor for stroke and vascular dementia. Curr. Neurol. Neurosci. Rep. 18, 53. DOI |
78 | Czeisler, C. A., Dumont, M., Duffy, J. F., Steinberg, J. D., Richardson, G. S., Brown, E. N., Sanchez, R., Rios, C. D. and Ronda, J. M. (1992) Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet 340, 933-936. DOI |
79 | Dagan, Y. (2002) Circadian rhythm sleep disorders (CRSD). Sleep Med. Rev. 6, 45-55. DOI |
80 | de Almondes, K. M., Costa, M. V., Malloy-Diniz, L. F. and Diniz, B. S. (2016) Insomnia and risk of dementia in older adults: systematic review and meta-analysis. J. Psychiatr. Res. 77, 109-115. DOI |
81 | Earley, C. J. and Silber, M. H. (2010) Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med. 11, 807-815. DOI |
82 | de Gage, S. B., Begaud, B., Bazin, F., Verdoux, H., Dartigues, J. F., Peres, K., Kurth, T. and Pariente, A. (2012) Benzodiazepine use and risk of dementia: prospective population based study. BMJ 345, e6231. DOI |
83 | Diekelmann, S. and Born, J. (2010) The memory function of sleep. Nat. Rev. Neurosci. 11, 114-126. DOI |
84 | Duran, J., Esnaola, S., Rubio, R. and Iztueta, A. (2001) Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am. J. Respir. Crit. Care Med. 163, 685-689. DOI |
85 | Elwood, P. C., Bayer, A. J., Fish, M., Pickering, J., Mitchell, C. and Gallacher, J. E. (2011) Sleep disturbance and daytime sleepiness predict vascular dementia. J. Epidemiol. Community Health 65, 820-824. DOI |
86 | Erman, M., Seiden, D., Zammit, G., Sainati, S. and Zhang, J. (2006) An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med. 7, 17-24. DOI |
87 | Evans, S. M., Haney, M., Fischman, M. W. and Foltin, R. W. (1999) Limited sex differences in response to “binge” smoked cocaine use in humans. Neuropsychopharmacology 21, 445-454. DOI |
88 | Fantini, M. L., Postuma, R. B., Montplaisir, J. and Ferini-Strambi, L. (2006) Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res. Bull. 70, 386-390. DOI |
89 | Dauvilliers, Y. and Buguet, A. (2005) Hypersomnia. Dialogues Clin. Neurosci. 7, 347-356. DOI |
90 | Krueger, J. M., Frank, M. G., Wisor, J. P. and Roy, S. (2016) Sleep function: toward elucidating an enigma. Sleep Med. Rev. 28, 46-54. DOI |
91 | Kushida, C. A., Littner, M. R., Hirshkowitz, M., Morgenthaler, T. I., Alessi, C. A., Bailey, D., Boehlecke, B., Brown, T. M., Coleman, J., Jr., Friedman, L., Kapen, S., Kapur, V. K., Kramer, M., Lee-Chiong, T., Owens, J., Pancer, J. P., Swick, T. J. and Wise, M. S.; American Academy of Sleep Medicine (2006) Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 29, 375-380. DOI |
92 | Lanctot, K. L., Herrmann, N., Mazzotta, P., Khan, L. R. and Ingber, N. (2004) GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Can. J. Psychiatry 49, 439-453. DOI |
93 | Sharma, M. K., Kainth, S., Kumar, S., Bhardwaj, A., Agarwal, H. K., Maiwall, R., Jamwal, K. D., Shasthry, S. M., Jindal, A., Choudhary, A., Anand, L., Dhamija, R. M., Kumar, G., Sharma, B. C. and Sarin, S. K. (2019) Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: a randomized, placebo-controlled trial. Clin. Mol. Hepatol. 25, 199-209. DOI |
94 | Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N. and Heald, J. L. (2017) Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J. Clin. Sleep Med. 13, 307-349. DOI |
95 | Satlin, A., Volicer, L., Stopa, E. G. and Harper, D. (1995) Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiol. Aging 16, 765-771. DOI |
96 | Schenck, C. H., Bundlie, S. R. and Mahowald, M. W. (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46, 388-393. DOI |
97 | Shi, L., Chen, S. J., Ma, M. Y., Bao, Y. P., Han, Y., Wang, Y. M., Shi, J., Vitiello, M. V. and Lu, L. (2018) Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med. Rev. 40, 4-16. DOI |
98 | Shih, H. I., Lin, C. C., Tu, Y. F., Chang, C. M., Hsu, H. C., Chi, C. H. and Kao, C. H. (2015) An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study. Medicine (Baltimore) 94, e809. DOI |
99 | Silber, M. H. (2013) Sleep-related movement disorders. Continuum (Minneap. Minn.) 19, 170-184. DOI |
100 | Shimohama, S., Taniguchi, T., Fujiwara, M. and Kameyama, M. (1988) Changes in benzodiazepine receptors in Alzheimer-type dementia. Ann. Neurol. 23, 404-406. DOI |
101 | Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S. and Badr, S. (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328, 1230-1235. DOI |
102 | Wing, Y. K., Lam, S. P., Zhang, J., Leung, E., Ho, C. L., Chen, S., Cheung, M. K., Li, S. X., Chan, J. W., Mok, V., Tsoh, J., Chan, A. and Ho, C. K. (2015) Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression. Neurology 84, 516-522. DOI |
103 | Wing, Y. K., Li, S. X., Mok, V., Lam, S. P., Tsoh, J., Chan, A., Yu, M. W., Lau, C. Y., Zhang, J. and Ho, C. K. (2012) Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 83, 470-472. DOI |
104 | Xie, Z., Chen, F., Li, W. A., Geng, X., Li, C., Meng, X., Feng, Y., Liu, W. and Yu, F. (2017) A review of sleep disorders and melatonin. Neurol. Res. 39, 559-565. DOI |
105 | Yaffe, K., Laffan, A. M., Harrison, S. L., Redline, S., Spira, A. P., Ensrud, K. E., Ancoli-Israel, S. and Stone, K. L. (2011) Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 306, 613-619. |
106 | Yayeh, T., Leem, Y. H., Kim, K. M., Jung, J. C., Schwarz, J., Oh, K. W. and Oh, S. (2018) Administration of alphas1-casein hydrolysate increases sleep and modulates GABAA receptor subunit expression. Biomol. Ther. (Seoul) 26, 268-273. DOI |
107 | Young, T. and Peppard, P. (2000) Sleep-disordered breathing and cardiovascular disease: epidemiologic evidence for a relationship. Sleep 23, S122-S126. |
108 | Zammit, G., Erman, M., Wang-Weigand, S., Sainati, S., Zhang, J. and Roth, T. (2007) Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J. Clin. Sleep Med. 3, 495-504. DOI |
109 | Zhou, J., Zhang, J., Lam, S. P., Chan, J. W., Mok, V., Chan, A., Li, S. X., Liu, Y., Tang, X., Yung, W. H. and Wing, Y. K. (2017) Excessive daytime sleepiness predicts neurodegeneration in idiopathic REM sleep behavior disorder. Sleep 40, doi: 10.1093/sleep/zsx041. |
110 | Zucker, I. and Beery, A. K. (2010) Males still dominate animal studies. Nature 465, 690. DOI |
111 | Spira, A. P., Gamaldo, A. A., An, Y., Wu, M. N., Simonsick, E. M., Bilgel, M., Zhou, Y., Wong, D. F., Ferrucci, L. and Resnick, S. M. (2013) Self-reported sleep and beta-amyloid deposition in communitydwelling older adults. JAMA Neurol. 70, 1537-1543. DOI |
112 | Silvia, R., Mor, M., Bedini, A., Spadoni, G. and Tarzia, G. (2008) Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders. Curr. Top. Med. Chem. 8, 954-968. DOI |
113 | Singareddy, R., Vgontzas, A. N., Fernandez-Mendoza, J., Liao, D., Calhoun, S., Shaffer, M. L. and Bixler, E. O. (2012) Risk factors for incident chronic insomnia: a general population prospective study. Sleep Med. 13, 346-353. DOI |
114 | Singer, H. S., Mink, J. W., Gilbert, D. L. and Jankovic, J. (2016) Chapter 19-Movements that occur in sleep. In Movement Disorders in Childhood (2nd ed.) (H. S. Singer, J. W. Mink, D. L. Gilbert and J. Jankovic, Eds.), pp. 427-451. Academic Press, Boston. |
115 | Susic, V. (2007) Normal sleep. Glas-Srpska Akademija Nauka I Umetnosti 49, 1-6. |
116 | Tannenbaum, C., Greaves, L. and Graham, I. D. (2016) Why sex and gender matter in implementation research. BMC Med. Res. Methodol. 16, 145. DOI |
117 | Tannenbaum, C., Paquette, A., Hilmer, S., Holroyd-Leduc, J. and Carnahan, R. (2012) A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging 29, 639-658. DOI |
118 | Tranah, G. J., Blackwell, T., Stone, K. L., Ancoli-Israel, S., Paudel, M. L., Ensrud, K. E., Cauley, J. A., Redline, S., Hillier, T. A., Cummings, S. R. and Yaffe, K.; SOF Research Group (2011) Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann. Neurol. 70, 722-732. DOI |
119 | Tholfsen, L. K., Larsen, J. P., Schulz, J., Tysnes, O. B. and Gjerstad, M. D. (2015) Development of excessive daytime sleepiness in early Parkinson disease. Neurology 85, 162-168. DOI |
120 | Thorpy, M. J. (2012) Classification of sleep disorders. Neurotherapeutics 9, 687-701. DOI |
121 | Tsuno, N., Jaussent, I., Dauvilliers, Y., Touchon, J., Ritchie, K. and Besset, A. (2007) Determinants of excessive daytime sleepiness in a French community-dwelling elderly population. J. Sleep Res. 16, 364-371. DOI |
122 | Vansickel, A. R., Stoops, W. W. and Rush, C. R. (2010) Human sex differences in d-amphetamine self-administration. Addiction 105, 727-731. DOI |
123 | Wang, J. and Huang, Y. (2007) Pharmacogenomics of sex difference in chemotherapeutic toxicity. Curr. Drug Discov. Technol. 4, 59-68. DOI |
124 | Wadworth, A. N. and McTavish, D. (1993) Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs Aging 3, 441-459. DOI |
125 | Wagner, J. and Wagner, M. L. (2000) Non-benzodiazepines for the treatment of insomnia. Sleep Med. Rev. 4, 551-581. DOI |
126 | Wan, H., Warburton, E. C., Zhu, X. O., Koder, T. J., Park, Y., Aggleton, J. P., Cho, K., Bashir, Z. I. and Brown, M. W. (2004) Benzodiazepine impairment of perirhinal cortical plasticity and recognition memory. Eur. J. Neurosci. 20, 2214-2224. DOI |
127 | Wing, Y. K., Lam, S. P., Li, S. X., Yu, M. W., Fong, S. Y., Tsoh, J. M., Ho, C. K. and Lam, V. K. (2008) REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison. J. Neurol. Neurosurg. Psychiatry 79, 1415-1416. DOI |
128 | Leufkens, T. R. and Vermeeren, A. (2014) Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies. Clin. Ther. 36, 141-150. DOI |
129 | Lee-Iannotti, J. K. and Parish, J. M. (2016) Suvorexant: a promising, novel treatment for insomnia. Neuropsychiatr Dis. Treat. 12, 491-495. |
130 | Lee, J., Jung, S. J., Choi, J. W., Shin, A. and Lee, Y. J. (2018) Use of sedative-hypnotics and the risk of Alzheimer’s dementia: a retrospective cohort study. PLoS ONE 13, e0204413. DOI |
131 | Lin, C. C., Chou, C. H., Fan, Y. M., Yin, J. H., Chung, C. H., Chien, W. C., Sung, Y. F., Tsai, C. K., Lin, G. Y., Lin, Y. K. and Lee, J. T. (2015) Increased risk of dementia among sleep-related movement disorders: a population-based longitudinal study in Taiwan. Medicine (Baltimore) 94, e2331. DOI |
132 | Lopes Da Silva, F. H. and Storm Van Leeuwen, W. (1977) The cortical source of the alpha rhythm. Neurosci. Lett. 6, 237-241. DOI |
133 | Martinelli, P., Contin, M., Scaglione, C., Riva, R., Albani, F. and Baruzzi, A. (2003) Levodopa pharmacokinetics and dyskinesias: are there sex-related differences? Neurol. Sci. 24, 192-193. DOI |
134 | Lumeng, J. C. and Chervin, R. D. (2008) Epidemiology of pediatric obstructive sleep apnea. Proc. Am. Thorac. Soc. 5, 242-252. DOI |
135 | Macey, P. M., Haris, N., Kumar, R., Thomas, M. A., Woo, M. A. and Harper, R. M. (2018) Obstructive sleep apnea and cortical thickness in females and males. PLoS ONE 13, e0193854. DOI |
136 | Mahlknecht, P., Iranzo, A., Hogl, B., Frauscher, B., Muller, C., Santamaria, J., Tolosa, E., Serradell, M., Mitterling, T., Gschliesser, V., Goebel, G., Brugger, F., Scherfler, C., Poewe, W. and Seppi, K.; Sleep Innsbruck Barcelona Group (2015) Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology 84, 654-658. DOI |
137 | Mannucci, C., Pichini, S., Spagnolo, E. V., Calapai, F., Gangemi, S., Navarra, M. and Calapai, G. (2018) Sodium oxybate therapy for alcohol withdrawal syndrome and keeping of alcohol abstinence. Curr. Drug Metab. 19, 1056-1064. DOI |
138 | Marion, M. H., Qurashi, M., Marshall, G. and Foster, O. (2008) Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease? J. Neurol. 255, 192-196. DOI |
139 | Molano, J., Boeve, B., Ferman, T., Smith, G., Parisi, J., Dickson, D., Knopman, D., Graff-Radford, N., Geda, Y., Lucas, J., Kantarci, K., Shiung, M., Jack, C., Silber, M., Pankratz, V. S. and Petersen, R. (2010) Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain 133, 540-556. DOI |
140 | Moreira, F. A., Jupp, B., Belin, D. and Dalley, J. W. (2015) Endocannabinoids and striatal function: implications for addiction-related behaviours. Behav. Pharmacol. 26, 59-72. DOI |
141 | Oginska, H., Pokorski, J. and Oginski, A. (1993) Gender, ageing, and shiftwork intolerance. Ergonomics 36, 161-168. DOI |
142 | Paine, S. J., Fink, J., Gander, P. H. and Warman, G. R. (2014) Identifying advanced and delayed sleep phase disorders in the general population: a national survey of New Zealand adults. Chronobiol. Int. 31, 627-636. DOI |
143 | Morgenthaler, T. I., Kapur, V. K., Brown, T., Swick, T. J., Alessi, C., Aurora, R. N., Boehlecke, B., Chesson, A. L., Jr., Friedman, L., Maganti, R., Owens, J., Pancer, J. and Zak, R.; Standards of Practice Committee of the American Academy of Sleep Medicine (2007) Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 30, 1705-1711. DOI |
144 | Morphy, H., Dunn, K. M., Lewis, M., Boardman, H. F. and Croft, P. R. (2007) Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 30, 274-280. |
145 | Neubauer, D. N. (2008) A review of ramelteon in the treatment of sleep disorders. Neuropsychiatr. Dis. Treat. 4, 69-79. DOI |
146 | Nomura, T., Inoue, Y., Kagimura, T. and Nakashima, K. (2013) Clinical significance of REM sleep behavior disorder in Parkinson's disease. Sleep Med. 14, 131-135. DOI |
147 | Ohayon, M. M., Lemoine, P., Arnaud-Briant, V. and Dreyfus, M. (2002) Prevalence and consequences of sleep disorders in a shift worker population. J. Psychosom. Res. 53, 577-583. DOI |
148 | Ohayon, M. M., O'Hara, R. and Vitiello, M. V. (2012) Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med. Rev. 16, 283-295. DOI |
149 | Ohayon, M. M. and Roth, T. (2002) Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J. Psychosom. Res. 53, 547-554. DOI |
150 | Patil, S. P., Ayappa, I. A., Caples, S. M., Kimoff, R. J., Patel, S. R. and Harrod, C. G. (2019) Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine clinical practice guideline. J. Clin. Sleep Med. 15, 335-343. DOI |
151 | Paudel, M. L., Taylor, B. C., Ancoli-Israel, S., Blackwell, T., Stone, K. L., Tranah, G., Redline, S., Cummings, S. R. and Ensrud, K. E.; Osteoporotic Fractures in Men (MrOS) Study (2010) Rest/activity rhythms and mortality rates in older men: MrOS Sleep Study. Chronobiol. Int. 27, 363-377. DOI |
152 | Pase, M. P., Himali, J. J., Grima, N. A., Beiser, A. S., Satizabal, C. L., Aparicio, H. J., Thomas, R. J., Gottlieb, D. J., Auerbach, S. H. and Seshadri, S. (2017) Sleep architecture and the risk of incident dementia in the community. Neurology 89, 1244-1250. DOI |
153 | Pakes, G. E., Brogden, R. N., Heel, R. C., Speight, T. M. and Avery, G. S. (1981) Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 22, 81-110. DOI |
154 | Pallesen, S., Nordhus, I. H., Omvik, S., Sivertsen, B., Tell, G. S. and Bjorvatn, B. (2007) Prevalence and risk factors of subjective sleepiness in the general adult population. Sleep 30, 619-624. DOI |
155 | Pandi-Perumal, S. R., Trakht, I., Srinivasan, V., Spence, D. W., Maestroni, G. J., Zisapel, N. and Cardinali, D. P. (2008) Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog. Neurobiol. 85, 335-353. DOI |
156 | Pat McAndrews, M., Weiss, R. T., Sandor, P., Taylor, A., Carlen, P. L. and Shapiro, C. M. (2003) Cognitive effects of long-term benzodiazepine use in older adults. Hum. Psychopharmacol. 18, 51-57. DOI |
157 | Paterniti, S., Dufouil, C., Bisserbe, J. C. and Alperovitch, A. (1999) Anxiety, depression, psychotropic drug use and cognitive impairment. Psychol. Med. 29, 421-428. DOI |
158 | Postuma, R. B., Gagnon, J. F., Bertrand, J. A., Genier Marchand, D. and Montplaisir, J. Y. (2015b) Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology 84, 1104-1113. DOI |
159 | Pigeon, W. R. and Yurcheshen, M. (2009) Behavioral sleep medicine interventions for Restless Legs Syndrome and Periodic Limb Movement Disorder. Sleep Med. Clin. 4, 487-494. DOI |
160 | Postuma, R. B., Adler, C. H., Dugger, B. N., Hentz, J. G., Shill, H. A., Driver-Dunckley, E., Sabbagh, M. N., Jacobson, S. A., Belden, C. M., Sue, L. I., Serrano, G. and Beach, T. G. (2015a) REM sleep behavior disorder and neuropathology in Parkinson's disease. Mov. Disord. 30, 1413-1417. DOI |
161 | Postuma, R. B., Montplaisir, J., Lanfranchi, P., Blais, H., Rompre, S., Colombo, R. and Gagnon, J. F. (2011) Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder. Mov. Disord. 26, 1529-1533. DOI |
162 | Punjabi, N. M., Shahar, E., Redline, S., Gottlieb, D. J., Givelber, R. and Resnick, H. E.; Sleep Heart Health Study Investigators (2004) Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol. 160, 521-530. DOI |
163 | Rangel-Barajas, C., Coronel, I. and Floran, B. (2015) Dopamine receptors and neurodegeneration. Aging Dis. 6, 349-368. DOI |
164 | Rezvani, M., Zamani, B. and Fereshtehnejad, S. M. (2013) Factors affecting the efficacy of pramipexole in patients with restless legs syndrome. Acta Med. Iran. 51, 377-385. |
165 | Romenets, S. R., Gagnon, J. F., Latreille, V., Panniset, M., Chouinard, S., Montplaisir, J. and Postuma, R. B. (2012) Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Mov. Disord. 27, 996-1003. DOI |
166 | Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W. and Hla, K. M. (2013) Increased prevalence of sleep-disordered breathing in adults. Am. J. Epidemiol. 177, 1006-1014. DOI |
167 | Phillips, B. and Mannino, D. (2005) Correlates of sleep complaints in adults: the ARIC study. J. Clin. Sleep Med. 1, 277-283. DOI |
168 | Rissman, R. A., De Blas, A. L. and Armstrong, D. M. (2007) GABA(A) receptors in aging and Alzheimer's disease. J. Neurochem. 103, 1285-1292. DOI |
169 | Roman, G. C. (1987) Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA 258, 1782-1788. DOI |
170 | Romeijn, N., Raymann, R. J., Most, E., Te Lindert, B., Van Der Meijden, W. P., Fronczek, R., Gomez-Herrero, G. and Van Someren, E. J. (2012) Sleep, vigilance, and thermosensitivity. Pflugers Arch. 463, 169-176. DOI |
171 | Saias, T. and Gallarda, T. (2008) Aggressive reactions under benzodiazepines: a review of the literature. Encephale 34, 330-336. DOI |
172 | Sack, R. L., Auckley, D., Auger, R. R., Carskadon, M. A., Wright, K. P., Jr., Vitiello, M. V. and Zhdanova, I. V.; American Academy of Sleep Medicine (2007) Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep 30, 1460-1483. DOI |
173 | Sancar, F., Ericksen, S. S., Kucken, A. M., Teissere, J. A. and Czajkowski, C. (2007) Structural determinants for high-affinity zolpidem binding to GABA-A receptors. Mol. Pharmacol. 71, 38-46. DOI |
174 | Sateia, M. J. (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146, 1387-1394. DOI |
175 | Rhyne, D. N. and Anderson, S. L. (2015) Suvorexant in insomnia: efficacy, safety and place in therapy. Ther. Adv. Drug Saf. 6, 189-195. DOI |